Valence Life Sciences

CalciMedica, Inc. is a biotechnology company based in La Jolla, California, focused on the discovery and development of small molecule drugs aimed at treating autoimmune and inflammatory diseases. Founded in December 2006 by a team of scientists with backgrounds in calcium signaling, the company specializes in the targeted inhibition of calcium release-activated calcium channels, a key mechanism in immune response regulation. The founding team includes individuals who previously collaborated at TorreyPines Therapeutics and the CBR Institute, where they made significant contributions to understanding calcium signaling pathways. Through its innovative research, CalciMedica aims to develop effective therapies for patients suffering from various autoimmune conditions.

CalciMedica, Inc. is a biotechnology company based in La Jolla, California, focused on the discovery and development of small molecule drugs aimed at treating autoimmune and inflammatory diseases. Founded in December 2006 by a team of scientists with backgrounds in calcium signaling, the company specializes in the targeted inhibition of calcium release-activated calcium channels, a key mechanism in immune response regulation. The founding team includes individuals who previously collaborated at TorreyPines Therapeutics and the CBR Institute, where they made significant contributions to understanding calcium signaling pathways. Through its innovative research, CalciMedica aims to develop effective therapies for patients suffering from various autoimmune conditions.

JenaValve Technology GmbH specializes in the development and manufacturing of transcatheter aortic valve implantation (TAVI) systems designed for both transapical and transfemoral implantation. Founded in 2006 and headquartered in Munich, Germany, the company offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The concept for the device was initiated by cardiologists Hans-Reiner Figulla and Markus Ferrari at the Friedrich Schiller University Clinic in Jena, Germany. Early on, JenaValve recognized the importance of safety, precision, and durability in their systems, which are crucial for effective treatment and enhancing patient well-being.

Invuity, Inc. is a medical technology company specializing in the development and marketing of illuminated surgical devices in the United States and Asia. Utilizing its intelligent photonics technology platform, Invuity creates both single-use and reusable devices that enhance visibility during surgeries. Its product offerings include various illuminated retractor systems and handheld illuminators designed for a range of surgical applications, including breast, orthopedic, spine, cardiothoracic, and gynecological procedures. The BriteField Port System and BriteField McCulloch retractor are notable products that facilitate illumination and visualization during minimally invasive surgeries. Invuity sells its devices through a network of direct sales representatives and independent agents, as well as directly to hospitals and surgeons. Founded in 2004 and headquartered in San Francisco, California, Invuity was previously known as Spotlight Surgical, Inc. and has been operating as a subsidiary of Stryker Corporation since 2018.

Invuity, Inc. is a medical technology company specializing in the development and marketing of illuminated surgical devices in the United States and Asia. Utilizing its intelligent photonics technology platform, Invuity creates both single-use and reusable devices that enhance visibility during surgeries. Its product offerings include various illuminated retractor systems and handheld illuminators designed for a range of surgical applications, including breast, orthopedic, spine, cardiothoracic, and gynecological procedures. The BriteField Port System and BriteField McCulloch retractor are notable products that facilitate illumination and visualization during minimally invasive surgeries. Invuity sells its devices through a network of direct sales representatives and independent agents, as well as directly to hospitals and surgeons. Founded in 2004 and headquartered in San Francisco, California, Invuity was previously known as Spotlight Surgical, Inc. and has been operating as a subsidiary of Stryker Corporation since 2018.

Celator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1 (Irinotecan HCI-Floxuridine), a treatment for colorectal cancer; and CPX-351 (Cytarabine-Daunorubicin), a treatment for acute myeloid leukemia (AML). Celator Pharmaceuticals, Inc. was formerly known as Celator Technologies, Inc. The company was founded in 2000 and is headquartered in Princeton, New Jersey.

Invuity, Inc. is a medical technology company specializing in the development and marketing of illuminated surgical devices in the United States and Asia. Utilizing its intelligent photonics technology platform, Invuity creates both single-use and reusable devices that enhance visibility during surgeries. Its product offerings include various illuminated retractor systems and handheld illuminators designed for a range of surgical applications, including breast, orthopedic, spine, cardiothoracic, and gynecological procedures. The BriteField Port System and BriteField McCulloch retractor are notable products that facilitate illumination and visualization during minimally invasive surgeries. Invuity sells its devices through a network of direct sales representatives and independent agents, as well as directly to hospitals and surgeons. Founded in 2004 and headquartered in San Francisco, California, Invuity was previously known as Spotlight Surgical, Inc. and has been operating as a subsidiary of Stryker Corporation since 2018.

Invuity, Inc. is a medical technology company specializing in the development and marketing of illuminated surgical devices in the United States and Asia. Utilizing its intelligent photonics technology platform, Invuity creates both single-use and reusable devices that enhance visibility during surgeries. Its product offerings include various illuminated retractor systems and handheld illuminators designed for a range of surgical applications, including breast, orthopedic, spine, cardiothoracic, and gynecological procedures. The BriteField Port System and BriteField McCulloch retractor are notable products that facilitate illumination and visualization during minimally invasive surgeries. Invuity sells its devices through a network of direct sales representatives and independent agents, as well as directly to hospitals and surgeons. Founded in 2004 and headquartered in San Francisco, California, Invuity was previously known as Spotlight Surgical, Inc. and has been operating as a subsidiary of Stryker Corporation since 2018.